Evidence map›Paper›PMID 31738934›Full record

ArticleEuropean journal of pharmacology2019

Δ

Nissar A Darmani, Louiza Belkacemi, Weixia Zhong

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. The Cannabinoid CBInternational journal of molecular sciences · 2025
    Article
  3. Endocannabinoid signaling in stress, nausea, and vomiting.Neurogastroenterology and motility · 2025
    Review
  4. Review
  5. Article
  6. Phytochemical Constituents and Derivatives ofInternational journal of molecular sciences · 2023
    Review
  7. Article
  8. Signal transduction pathways involved in dopamine DAutonomic neuroscience : basic & clinical · 2021
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nissar A DarmaniDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, 91766, USA. Electronic address: ndarmani@westernu.edu.
Louiza BelkacemiDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, 91766, USA.
Weixia ZhongDepartment of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, 91766, USA.
Western University of Health Sciences · US

Funding

Substance P tachykininergic NK1 receptor emetic signal transduction pathwaysR01CA207287 · NCI · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI DARMANI, NISSAR A · 2017 to 2021
$1.5M
NCI NIH HHS R01 CA207287
6 · The paper itself

Abstract

Δ

Indexed as

AnimalsBenzoxazinesCannabinoid Receptor AgonistsCannabinoidsCyclohexanolsDronabinolFemaleMaleMorpholinesNaphthalenesPeptide FragmentsReceptors, Neurokinin-1ShrewsSubstance PVomiting3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBenzoxazinesCannabinoid Receptor AgonistsCannabinoidsCyclohexanolsDronabinolGR 73632MorpholinesNaphthalenesPeptide FragmentsReceptors, Neurokinin-1Substance P(9)-THCCannabinoid CB(1) receptorGR73632SR141716ASubstance PVomitingΔ

Identifiers

PMID31738934
PMCPMC6910216
OpenAlexW2988042044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.